Bioequivalence studies at night [Regulatives / Guidelines]

posted by Loky do – Egypt, 2022-03-28 14:36 (751 d 02:37 ago) – Posting: # 22875
Views: 1,552


Are there any objections (regulatory or in guidelines) or negative effect on the PK of drugs when conducting Bioequivalence studies at night (i.e. volunteers will fast over day and dose will be administrated at night) the dosing hours will be standardized through volunteers and phases? Also the fasting hours before dosing to volunteers as per guidelines are at least 8-10 hours, if it reached 14 hours could it affect the PK of the drug also?

Thanks in advance

Complete thread:

UA Flag
 Admin contact
22,985 posts in 4,823 threads, 1,653 registered users;
42 visitors (0 registered, 42 guests [including 2 identified bots]).
Forum time: 17:13 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz